Such a scenario poses limitations to the straightforward inhibition of either STAT3 or STAT5 in NK cells and necessitates elucidating how the STAT3/STAT5 ratio is regulated and what is its contribution to the melanoma–NK cells interplay. This evidence concerns the gene STAT5B and melanoma.